Senator Markwayne Mullin (R-Oklahoma) recently sold shares of Danaher Co. NYSE: DHR. In a filing disclosed on February 27th, the Senator disclosed that they had sold between $15,001 and $50,000 in Danaher stock on February 13th.
Senator Markwayne Mullin also recently made the following trade(s):
- Purchased $15,001 - $50,000 in shares of Amazon.com NASDAQ: AMZN on 2/13/2025.
- Sold $15,001 - $50,000 in shares of Honeywell International NASDAQ: HON on 2/13/2025.
- Purchased $15,001 - $50,000 in shares of IQVIA NYSE: IQV on 2/13/2025.
- Sold $15,001 - $50,000 in shares of Brick TSE: BRK on 2/13/2025.
- Sold $100,001 - $250,000 in shares of Vanguard Materials ETF NYSEARCA: VAW on 2/13/2025.
- Purchased $50,001 - $100,000 in shares of Microsoft NASDAQ: MSFT on 2/13/2025.
- Sold $15,001 - $50,000 in shares of Constellation Brands NYSE: STZ on 2/13/2025.
- Purchased $50,001 - $100,000 in shares of LPL Financial NASDAQ: LPLA on 2/13/2025.
- Purchased $15,001 - $50,000 in shares of TJX Companies NYSE: TJX on 2/13/2025.
- Sold $50,001 - $100,000 in shares of Advanced Micro Devices NASDAQ: AMD on 2/13/2025.
Danaher Trading Up 1.0 %
Shares of NYSE DHR traded up $2.02 during trading hours on Friday, hitting $207.73. The company's stock had a trading volume of 3,819,039 shares, compared to its average volume of 4,581,973. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The stock has a market cap of $148.47 billion, a price-to-earnings ratio of 39.34, a P/E/G ratio of 2.66 and a beta of 0.83. Danaher Co. has a 12 month low of $196.80 and a 12 month high of $281.70. The business has a 50-day simple moving average of $225.00 and a 200-day simple moving average of $245.50.
Danaher (NYSE:DHR - Get Free Report) last posted its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the previous year, the firm earned $2.09 EPS. On average, analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current fiscal year.
Danaher Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a $0.32 dividend. The ex-dividend date is Friday, March 28th. This is a boost from Danaher's previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a dividend yield of 0.62%. Danaher's dividend payout ratio (DPR) is presently 24.24%.
Institutional Investors Weigh In On Danaher
Hedge funds have recently added to or reduced their stakes in the stock. Heck Capital Advisors LLC purchased a new stake in Danaher during the 4th quarter valued at $27,000. Decker Retirement Planning Inc. purchased a new stake in Danaher during the 4th quarter valued at $31,000. Golden State Wealth Management LLC purchased a new stake in Danaher during the 4th quarter valued at $31,000. Strategic Financial Concepts LLC purchased a new stake in Danaher during the 4th quarter valued at $31,000. Finally, Pineridge Advisors LLC raised its stake in Danaher by 63.3% during the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock valued at $34,000 after buying an additional 57 shares during the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.
Insider Activity
In other news, SVP Brian W. Ellis sold 5,700 shares of the business's stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the sale, the senior vice president now owns 20,230 shares of the company's stock, valued at $4,534,149.90. The trade was a 21.98 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 11.10% of the company's stock.
Wall Street Analyst Weigh In
Several analysts have weighed in on DHR shares. Robert W. Baird cut their price objective on Danaher from $277.00 to $268.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 28th. Raymond James reaffirmed a "market perform" rating on shares of Danaher in a research report on Monday, February 3rd. The Goldman Sachs Group set a $250.00 price objective on Danaher in a research report on Wednesday, January 15th. Barclays cut their price objective on Danaher from $275.00 to $240.00 and set an "equal weight" rating on the stock in a research report on Thursday, January 30th. Finally, Wolfe Research raised Danaher from a "peer perform" rating to an "outperform" rating and set a $285.00 price target on the stock in a research report on Thursday, October 31st. Seven research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $278.00.
View Our Latest Stock Analysis on Danaher
About Senator Mullin
Markwayne Mullin (Republican Party) is a member of the U.S. Senate from Oklahoma. He assumed office on January 11, 2023. His current term ends on January 3, 2027. Mullin (Republican Party) ran in a special election to the U.S. Senate to represent Oklahoma. He won in the special general election on November 8, 2022. Mullin is a member of the Cherokee Nation and one of four Native American members of the 116th Congress. At the age of 20, Mullin took over his father's plumbing business. He is also a former professional mixed martial artist. Markwayne Mullin graduated from Stilwell High School. Mullin earned an associate degree in construction technology from Oklahoma State University Institute of Technology. His career experience includes owning and founding multiple businesses.
About Danaher
(
Get Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Further Reading
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
